Genetics & Genomics

Pharmacogenomic Testing and Warfarin Management

Andrea Maluso

pharmacogenetics, pharmacogenomics, warfarin, genetic testing
ONF 2015, 42(5), 563-565. DOI: 10.1188/15.ONF.563-565

Warfarin has been used for the prevention of thrombosis for more than 50 years and is the most frequently prescribed vitamin K antagonist in North America. Its mode of action is to prevent vitamin K from converting to vitamin KH2, thereby inhibiting clotting factors.

Members Only
Not a current ONS member or journal subscriber?

Become a Member

Explore the benefits of membership.
Join ONS or Renew Membership

Purchase This Article

Receive a PDF to download and print.